Business
Bionik Laboratories Corp. Appoints Dr. Eric Dusseux as Chief Executive Officer
Bionik Laboratories Corp. Appoints Dr. Eric Dusseux as Chief Executive Officer.
About this update from Bionik Laboratories Corp.
[{"type":"text","content":"\n\n\n\nBionik Laboratories Corp. Appoints Dr. Eric Dusseux as Chief Executive Officer\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBionik Laboratories Corp. Appoints Dr. Eric Dusseux as Chief Executive Officer\nPR Newswire\nTORONTO and BOSTON, Sept. 7, 2017\n\n\n\nTORONTO and BOSTON, Sept. 7, 2017 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQB: BNKL) (\"Bionik\" or the \"Company\"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced that the Board of Directors has appointed Dr. Eric Dusseux, a director of the Company since July 2017, as Chief Executive Officer, effective September 1, 2017.  Dr. Dusseux is a proven executive who has spent the past 15 years focused on helping companies in the healthcare sector develop and execute strategic growth and commercialization plans. Peter Bloch will continue to serve Bionik in the capacity as Chairman of the Board of Directors of the Company and will consult with the Company during the management transition. \n\n\"We are delighted that Eric has chosen to accept the role of Chief Executive Officer at Bionik,\" said Mr. Bloch.  \"His proven entrepreneurial ability to drive commercialization and growth strategy in domestic and international markets, and his experience in building and leading strategic alliances will be significant assets for Bionik.  Eric's appointment coincides with our efforts to expand our global sales and marketing efforts and develop strategic distribution agreements and partnerships targeting hospital and mass markets.\"\n\nCommenting on his appointment, Dr. Dusseux said, \"I am excited to be joining the management team of Bionik at a very important time for the Company.  We believe that the approach that the Company has taken to focus on evidence-based medicine results ahead of sales and marketing efforts both provides validation for our products and differentiates us from other companies in our field.  I look forward to broadening our i...